EUVIMEDEUVIMED entdecken
Open Access

Bone involvement in sarcoidosis: Insights from a multicentre Italian cohort.

Tommaso Pianigiani, Elisa Bianchi, Giulio Natalello, Roberto Barone, Francesca Aloe, Bianca Boncompagni, Elena Bargagli, Maria Antonietta Mazzei, Carla Caffarelli, Lucia Vietri, Alberto Papi, Luca Richeldi und 2 weitere

Sarcoidosis vasculitis and diffuse lung diseases · 22.06.2026 · 43 (2) · 17720-17720

DOI: 10.36141/svdld.2026.17720 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Sarcoidosis vasculitis and diffuse lung diseases, erschienen am 22.06.2026. Verfasst von Tommaso Pianigiani und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, Surgery and Neuroscience, Respiratory Disease and Lung Transplant Unit, University of Siena, Italy. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Sarcoidosis is a multisystemic granulomatous disease that can involve the skeletal system, although bone manifestations are considered relatively uncommon and often underdiagnosed. OBJECTIVES: To describe the prevalence, clinical characteristics, and treatment outcomes of bone involvement in a large multicenter Italian cohort of patients with sarcoidosis. METHODS: This retrospective, two-center observational study included 867 patients with histologically confirmed sarcoidosis followed at two Italian referral centers (2018-2025). Bone localization was identified by imaging (PET/CT, MRI, X-ray) and/or biopsy. Clinical, functional, laboratory, and therapeutic data were collected. RESULTS: Bone involvement was found in 46 patients (5.3%), predominantly women (58.7%), with mean age at diagnosis of 49.7 ± 12.2 years. Osseous lesions were most frequently localized in the axial skeleton, particularly pelvis (54.3%) and vertebrae (52.2%). Bone sarcoidosis was significantly associated with extra-thoracic lymphadenopathy, hepatic, and splenic involvement (p < 0.001), reflecting a pattern of clustered multi-organ disease. Osteoporosis and osteopenia were present in 15.2% and 13.0% of cases, respectively. Corticosteroid monotherapy was the most common initial treatment (56.5%), while 30.4% received combination therapy with csDMARDs or biologics. At one-year PET/CT re-evaluation, 56.5% showed a reduction of SUV at bone sites, with no significant correlation between therapeutic regimen and metabolic response. CONCLUSIONS: Bone involvement in sarcoidosis, though relatively rare, represents a clinically relevant phenotype strongly associated with hepatosplenic and lymphatic disease and characterized by a preferential axial skeleton localization. Recognition of this pattern is essential for diagnosis and management. Given the retrospective design and the limited follow-up sample, these findings should be interpreted with caution. Close radiological monitoring and tailored therapeutic strategies are warranted to improve outcomes.

Schlagwörter

sarcoidosisbone involvementbone sarcoidosisosteoporosisosteopeniaaxial skeletonpelvic involvementvertebral involvementcorticosteroid therapycsDMARDs

Autor:innen und Institutionen

  • Department of Medical Sciences, Surgery and Neuroscience, Respiratory Disease and Lung Transplant Unit, University of Siena, Italy.
  • Department of Health Sciences, University of Milan, Respiratory Unit ASST - Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Faculty of Medicine and Surgery, Catholic University of Sacred Heart, Rome, Italy.
  • Department of Respiratory Medicine, University of Ferrara Medical School, Ferrara, Italy.
  • Unit of Diagnostic Imaging, Department of Medical, Surgical and Neurosciences and of Radiological Sciences, University of Siena, Azienda Ospedaliero-Universitaria Senese, Siena, Italy.
  • Section of Internal Medicine, Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.

Zitieren

APA

Pianigiani, T., Bianchi, E., Natalello, G., Barone, R., Aloe, F., Boncompagni, B., Bargagli, E., Mazzei, M. A., Caffarelli, C., Vietri, L., Papi, A., Richeldi, L., Di Marco, F., & Cameli, P. (2026). Bone involvement in sarcoidosis: Insights from a multicentre Italian cohort. Sarcoidosis vasculitis and diffuse lung diseases, 43(2), 17720-17720. https://doi.org/10.36141/svdld.2026.17720

Vancouver

Pianigiani T, Bianchi E, Natalello G, Barone R, Aloe F, Boncompagni B, et al. Bone involvement in sarcoidosis: Insights from a multicentre Italian cohort. Sarcoidosis vasculitis and diffuse lung diseases. 2026;43(2):17720-17720. doi:10.36141/svdld.2026.17720

BibTeX
@article{Pianigiani2026,
  author = {Pianigiani, Tommaso and Bianchi, Elisa and Natalello, Giulio and Barone, Roberto and Aloe, Francesca and Boncompagni, Bianca and Bargagli, Elena and Mazzei, Maria Antonietta and Caffarelli, Carla and Vietri, Lucia and Papi, Alberto and Richeldi, Luca and Di Marco, Fabiano and Cameli, Paolo},
  title = {Bone involvement in sarcoidosis: Insights from a multicentre Italian cohort},
  journal = {Sarcoidosis vasculitis and diffuse lung diseases},
  year = {2026},
  volume = {43},
  number = {2},
  pages = {17720--17720},
  doi = {10.36141/svdld.2026.17720}
}
Kostenlos starten →